Good for you... I do believe the monoclonal (MAB) is what is luring the attention of the media so if Dr. Pourhassan puts that out to them, he may get more requests by them to interview him.

And by the way, Pourhassan started out the conversation saying "Leronlimab is a self-injectable once-a-week monoclonal antibody" ... and it looked like he was reading something prepared for this interview...